Atlas Trials

Efficacy and Tolerability of Xalatan in Patients

Clinical trial NCT00950690 · COMPLETED

Trial details

NCT number
NCT00950690
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
GlaucomaOcular Hypertension
Start date
2005-07-01
Primary completion
2007-12-01
Enrollment
1289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.